Phorbol-12-myristate-13-acetate effect on cyclic adenosine 3',5'-monophosphate levels in mouse skin and inhibition of phorbol-myristate-acetate-promoted tumorigenesis by theophylline
Belman, S.; Troll, W.
Cancer Research 34(12): 3446-3455
1974
ISSN/ISBN: 0008-5472
PMID: 4371963
Accession: 043937102
PDF emailed within 1 workday: $29.90
Related References
Krishnamurthi, S.; Joseph, S.; Kakkar, V.V. 1986: Synergistic potentiation of 5-hydroxytryptamine secretion by platelet agonists and phorbol myristate acetate despite inhibition of agonist-induced arachidonate/thromboxane and beta-thromboglobulin release and Ca2+ mobilization by phorbol myristate acetate Biochemical Journal 238(1): 193-199Segal, A.; Van Duuren, B.L.; Maté, U. 1975: The identification of phorbolol myristate acetate as a new metabolite of phorbol myristate acetate in mouse skin Cancer Research 35(8): 2154-2159
Belman, S.; Garte, S.J. 1980: Antagonism between phorbol myristate acetate and butyric acid on isoproterenol elevation of cyclic adenosine 3':5'-monophosphate and their effects on beta-adrenergic receptors in mouse epidermis Cancer Research 40(2): 240-244
Williams, J.M.; Dinarello, C.A.; Rosenwasser, L.J.; Kelley, V.; Reddish, M.; Strom, T.B. 1985: Phorbol myristate acetate protein complex mimics bioactivity of human interleukin 1 1. direct evidence that phorbol myristate acetate temporarily enters and is released from cellular compartment during superinduction protocol Lymphokine Research 4(4): 275-298
Shinichi, M.U.R.A.O.; Gemmell, M.A.; Callaham, M.F.; Anderson, N.L.; Huberman, E. 1983: Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate - Contrôle de la différenciation cellulaire dans des cellules leucémiques promyélocytaires HL-60, humaines par la 1,25-dihydroxyvitamine D3 et par le phorbol-12-myristate-13-acétate Cancer Research (Baltimore) 43(10): 4989-4996
Hadden, E.M.; Sadlik, J.R.; Coffey, R.G.; Hadden, J.W. 1982: Effect of phorbol myristate acetate and a lymphokine on cyclic 3':5'-guanosine monophosphate levels and proliferation of macrophages Cancer Research 42(8): 3064-3069
Belman, S.; Troll, W.; Garte, S.J. 1978: Effect of phorbol myristate acetate on cyclic nucleotide levels in mouse epidermis Cancer Research 38(9): 2978-2982
Tena-Sempere, M.; Pinilla, L.; Aguilar, E. 1996: In vitro pituitary GH secretion after GHRH, forskolin, dibutyryl cyclic-adenosine 3',5'-monophosphate and phorbol 12-myristate 13-acetate stimulation in long-term orchidectomized rats Journal of Molecular Endocrinology 16(1): 81-88
Szallasi, Z.; Blumberg, P.M. 1991: Prostratin, a nonpromoting phorbol ester, inhibits induction by phorbol 12-myristate 13-acetate of ornithine decarboxylase, edema, and hyperplasia in CD-1 mouse skin Cancer Research 51(19): 5355-5360
Szallasi, Z.; Blumberg, P.M. 1991: Porstatin, a nonpromoting phorbol ester, inhibits induction by phorbol 12-myristate 13-acetate of ornithine decarboxylase, edema, and hyperplasia in CD-1 mouse skin Cancer Research (Baltimore) 51(19): 5355-5360
Tremblay, Y.; Beaudoin, C. 1993: Regulation of 3β-hydroxysteroid dehydrogenase and 17β-hydroxysteroid dehydrogenase messenger ribonucleic acid levels by cyclic adenosine 3',5'-monophosphate and phorbol myristate acetate in human choriocarcinoma cells Molecular Endocrinology (Baltimore, Md.) 7(3): 355-364
Emerit, I.; Cerutti, P. 1983: Clastogenic action of tumor promoter phorbol-12-myristate-13 acetate in mixed human leukocyte cultures - Action clastogène du promoteur tumoral, le phorbol-12-myristate-13 acétate dans des cultures mixtes de leucocytes humains Carcinogenesis (New York. Print) 4(10): 1313-1316
Garte, S.J.; Belman, S. 1978: Effects of multiple phorbol myristate acetate treatments on cyclic nucleotide levels in mouse epidermis Biochemical and Biophysical Research Communications 84(2): 489-494
Schumacher, M. 1985: Inhibition of human chorionic gonadotropin stimulated adenylate cyclase in purified mouse leydig cells by the phorbol ester phorbol 12 myristate 13 acetate S Letters: 56-60
Kenneth Parkinson, E.; Emmerson, A. 1984: Non-promoting hyperplasiogenic agents do not mimic the effects of phorbol, 12-myristate, 13-acetate on terminal differentiation of normal and transformed human keratinocytes - Des agents hyperplasiogènes, non promoteurs, n'imitent pas les effets du phorbol, 12-myristate, 13-acétate sur la différenciation terminale des kératinocytes humains normaux et transformés Carcinogenesis (New York. Print) 5(5): 687-690
Garte, S.J.; Belman, S. 1980: Diurnal variation in cyclic nucleotide levels in normal and phorbol myristate acetate treated mouse epidermis Journal of Investigative Dermatology 74(4): 224-225
Sivak, A. 1977: Comparison of the biological activity of the tumor promotor phorbol myristate acetate and a metabolite, phorbolol myristate acetate, in the cell culture Cancer Letters 2(4): 285-289
Sivak, A. 1977: Comparison of the biological activity of the tumor promotor phorbol myristate acetate and a metabolite, phorbolol myristate acetate, in the cell culture Cancer Letters 2(4-5): 285-289
Kaminski, T.; Akinola, L.; Poutanen, M.; Vihko, R.; Vihko, P. 1997: Growth factors and phorbol-12-myristate-13-acetate modulate the follicle-stimulating hormone- and cyclic adenosine-3',5'-monophosphate-dependent regulation of 17beta-hydroxysteroid dehydrogenase type 1 expression in rat granulosa cells Molecular and Cellular Endocrinology 136(1): 47-56
Tremblay, Y.; Beaudoin, C. 1993: Regulation of 3 beta-hydroxysteroid dehydrogenase and 17 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid levels by cyclic adenosine 3',5'-monophosphate and phorbol myristate acetate in human choriocarcinoma cells Molecular Endocrinology 7(3): 355-364